Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: PROSTATIC NEOPLASMS - DIAGNOSIS , . Treffer: 30
2018
Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T
Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583
Doi: 10.1038/s41391-018-0068-3
Web of Science
PubMed
FullText
FullText_MUG
2017
Kaufmann, S; Mischinger, J; Amend, B; Rausch, S; Adam, M; Scharpf, M; Fend, F; Kramer, U; Notohamiprodjo, M; Nikolaou, K; Stenzl, A; Bedke, J; Kruck, S
First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.
World J Urol. 2017; 35(7):1023-1029
Doi: 10.1007/s00345-016-1970-8
Web of Science
PubMed
FullText
FullText_MUG
Smolle, MA; Bauernhofer, T; Pummer, K; Calin, GA; Pichler, M
Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Int J Mol Sci. 2017; 18(2):
Doi: 10.3390/ijms18020473
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155
Doi: 10.1007/978-3-319-42044-8_28
Web of Science
PubMed
FullText
FullText_MUG
Varma, M; Egevad, L; Algaba, F; Berney, D; Bubendorf, L; Camparo, P; Comperat, E; Erbersdobler, A; Griffiths, D; Grobholz, R; Haitel, A; Hulsbergen-van de Kaa, C; Langner, C; Loftus, B; Lopez-Beltran, A; Mayer, N; Nesi, G; Oliveira, P; Oxley, J; Rioux-Leclercq, N; Seitz, G; Shanks, J; Kristiansen, G
Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.
J Clin Pathol. 2016; 69(10):852-857
Doi: 10.1136/jclinpath-2016-203658
Web of Science
PubMed
FullText
FullText_MUG
2015
Augustin, H; Mayerhofer, K; Seles, M; Pummer, K
Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int. 2015; 95(2):125-131
Doi: 10.1159/000371895
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dahlhaus, A; Semlitsch, T; Jeitler, K; Horvath, K; Siebenhofer, A
Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
Fam Pract. 2015; 32(5):483-491
Doi: 10.1093/fampra/cmv053
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Gerger, A; Pichler, M
Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
World J Urol. 2015; 33(11):1661-1667
Doi: 10.1007/s00345-015-1494-7
Web of Science
PubMed
FullText
FullText_MUG
2014
Ponholzer, A; Trubel, S; Schramek, P; Wimpissinger, F; Feichtinger, H; Springer, C; Wehrberger, C; Fischereder, K; Pummer, K; Martini, T; Mayr, R; Pycha, A; Madersbacher, S
Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study.
World J Urol. 2014; 32(4):911-916
Doi: 10.1007/s00345-014-1252-2
Web of Science
PubMed
FullText
FullText_MUG
Pummer, K; Rieken, M; Augustin, H; Gutschi, T; Shariat, SF
Innovations in diagnostic imaging of localized prostate cancer.
World J Urol. 2014; 32(4):881-890
Doi: 10.1007/s00345-013-1172-6
Web of Science
PubMed
FullText
FullText_MUG
2013
Hansen, J; Auprich, M; Ahyai, SA; de, la, Taille, A; van, Poppel, H; Marberger, M; Stenzl, A; Mulders, PF; Huland, H; Fisch, M; Abbou, CC; Schalken, JA; Fradet, Y; Marks, LS; Ellis, W; Partin, AW; Pummer, K; Graefen, M; Haese, A; Walz, J; Briganti, A; Shariat, SF; Chun, FK
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
Eur Urol. 2013; 63(2):201-9
Doi: 10.1016/j.eururo.2012.07.030
Web of Science
PubMed
FullText
FullText_MUG
2012
Lee, DJ; Cha, EK; Dubin, JM; Beltran, H; Chromecki, TF; Fajkovic, H; Scherr, DS; Tagawa, ST; Shariat, SF
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
BJU Int. 2012; 109(7): 968-985.
Doi: 10.1111/j.1464-410X.2011.10643.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Auprich, M; Bjartell, A; Chun, FK; de la Taille, A; Freedland, SJ; Haese, A; Schalken, J; Stenzl, A; Tombal, B; van der Poel, H
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Eur Urol. 2011; 60(5):1045-1054
Doi: 10.1016/j.eururo.2011.08.003
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Auprich, M; Chun, FK; Ward, JF; Pummer, K; Babaian, R; Augustin, H; Luger, F; Gutschi, S; Budäus, L; Fisch, M; Huland, H; Graefen, M; Haese, A
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
Eur Urol. 2011; 59(1):96-105
Doi: 10.1016/j.eururo.2010.10.024
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2009
Fuchsjäger, M; Akin, O; Shukla-Dave, A; Pucar, D; Hricak, H
The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.
Clin Adv Hematol Oncol. 2009; 7(3):193-202
PubMed
Google Scholar
Fuchsjager, MH; Shukla-Dave, A; Hricak, H; Wang, L; Touijer, K; Donohue, JF; Eastham, JA; Kattan, MW
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy
BJU INT. 2009; 104(3): 315-320.
Doi: 10.1111/j.1464-410X.2009.08406.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2008
Bhojani, N; Perrotte, P; Hutterer, G; Suardi, N; Jeldres, C; Shariat, SF; Capitanio, U; Arjane, P; Widmer, H; Benard, F; Peloquin, F; Montorsi, F; Karakiewicz, P
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
J Sex Med. 2008; 5(9): 2141-2151.
Doi: 10.1111/j.1743-6109.2008.00811.x
Web of Science
PubMed
FullText
FullText_MUG
Fuchsjager, M; Shukla-Dave, A; Akin, O; Barentsz, J; Hricak, H
Prostate cancer imaging
Acta Radiol. 2008; 49(1):107-120
Doi: 10.1080/02841850701545821
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Vener, T; Derecho, C; Baden, J; Wang, H; Rajpurohit, Y; Skelton, J; Mehrotra, J; Varde, S; Chowdary, D; Stallings, W; Leibovich, B; Robin, H; Pelzer, A; Schäfer, G; Auprich, M; Mannweiler, S; Amersdorfer, P; Mazumder, A
Development of a multiplexed urine assay for prostate cancer diagnosis.
Clin Chem. 2008; 54(5): 874-882.
Doi: 10.1373/clinchem.2007.094912
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Karakiewicz, PI; Hutterer, GC
Predicting outcomes in patients with urologic cancers.
Curr Opin Support Palliat Care. 2007; 1(3): 153-168.
Doi: 10.1097/SPC.0b013e3282f125ec
PubMed
FullText
FullText_MUG
Pummer, K; Stettner, H; Augustin, H; Zigeuner, R; Habermann, H; Schips, L; Riedler, I; Trummer, H; Lipsky, K; Williams, SB
The use of body mass index to predict pathological stage in patients with clinically localized prostate cancer.
Onkologie. 2007; 30(10): 489-494.
Doi: 10.1159/0000106096
Web of Science
PubMed
FullText
FullText_MUG
2006
Augustin, H; Freibauer, C; Bayer, L; Lunglmayr, G; Tschurlovich, F; Kuber, W; Pummer, K
Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression.
Prostate Cancer Prostatic Dis. 2006; 9(3):279-283
Doi: 10.1038/sj.pcan.4500883
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2004
Hammerer, PG; Augustin, H; Blonski, J; Graefen, M; Haese, A; Erbersdobler, A; Daghofer, F; Huland, H
Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system
UROLOGE A. 2004; 43(3): 307-312.
Doi: 10.1007/s00120-004-0531-8
Web of Science
PubMed
FullText
FullText_MUG
Herrmann, W; Stöckle, M; Sand-Hill, M; Hübner, U; Herrmann, M; Obeid, R; Wullich, B; Loch, T; Geisel, J
The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen.
Clin Chem Lab Med. 2004; 42(9):1051-1057
Doi: 10.1515/CCLM.2004.211
Web of Science
PubMed
FullText
FullText_MUG
2003
Graefen, M; Augustin, H; Karakiewicz, PI; Hammerer, PG; Haese, A; Palisaar, J; Blonski, J; Fernandez, S; Erbersdobler, A; Huland, H
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.
EUR UROL. 2003; 43(1): 6-10.
Doi: 10.1016%2FS0302-2838%2802%2900497-9
Web of Science
PubMed
FullText
FullText_MUG
Zigeuner, RE; Lipsky, K; Riedler, I; Auprich, M; Schips, L; Salfellner, M; Pummer, K; Hubmer, G
Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients.
Urology. 2003; 62(3):451-455
Doi: 10.1016%2FS0090-4295%2803%2900459-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2002
Solakoglu, O; Maierhofer, C; Lahr, G; Breit, E; Scheunemann, P; Heumos, I; Pichlmeier, U; Schlimok, G; Oberneder, R; Kollermann, MW; Kollermann, J; Speicher, MR; Pantel, K
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors.
Proc Natl Acad Sci U S A. 2002; 99(4):2246-2251
Doi: 10.1073/pnas.042372199
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1999
Djavan, B; Bursa, B; Seitz, C; Soeregi, G; Remzi, M; Basharkhah, A; Wolfram, R; Marberger, M
Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection.
Urology. 1999; 54(4):603-606
Doi: 10.1016/s0090-4295(99)00280-0
Web of Science
PubMed
FullText
FullText_MUG
1980
Fotter, R; Sager, WD; Justich, E; zur Nedden, D
Importance of computer tomography in paediatric diagnostics of abdominal and pelvic tumours (author's transly
Rontgenblatter. 1980; 33(3): 156-162.
PubMed
1979
Fotter, R; Sager, WD
CT of the pelvis and abdomen during childhood (author's transl)
Rofo. 1979; 131(5): 476-479.
PubMed